Papillary Thyroid Carcinoma Variants
Open Access
- 8 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Head and Neck Pathology
- Vol. 5 (1), 51-56
- https://doi.org/10.1007/s12105-010-0236-9
Abstract
Papillary thyroid carcinomas are the most common thyroid cancers and constitute more than 70% of thyroid malignancies. The most common etiologic factor is radiation, but genetic susceptibility and other factors also contribute to the development of papillary thyroid carcinoma. The most common variants include conventional, follicular variant and tall cell variant. However, many other uncommon variants have been described including oncocytic, columnar cell, diffuse sclerosing and solid forms. Immunohistochemical staining with TTF-1 and thyroglobulin is very useful in confirming the diagnosis of papillary thyroid carcinoma especially in metastatic sites. Markers such as HBME-1 and CITED1 can assist in separating some difficult cases of follicular variants of papillary thyroid carcinomas from follicular adenomas. Molecular studies have shown that the BRAF V600E mutation is found mainly in papillary and anaplastic thyroid carcinomas. Other molecular markers such as HMGA2 and insulin-like growth factor II mRNA binding protein 3 have been used recently as molecular tests to separate papillary thyroid carcinoma and its variants from follicular adenomas and other benign thyroid nodules.Keywords
This publication has 20 references indexed in Scilit:
- HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodulesCancer Cytopathology, 2010
- Diagnostic Utility of IMP3 Expression in Thyroid NeoplasmsDiagnostic Molecular Pathology, 2010
- Papillary Thyroid Carcinoma With Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma. A Clinicopathologic, Immunohistochemical, and Molecular Study of Eight CasesThe American Journal of Surgical Pathology, 2010
- Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the YoungThyroid®, 2009
- The Delphian Lymph Node in Thyroid CancerAnnals of Surgery, 2008
- Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2006
- Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2006
- Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk groupJournal of Clinical Pathology, 2004
- Familial risk of cancer by site and histopathologyInternational Journal of Cancer, 2002
- Hürthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behaviorWorld Journal of Surgery, 1992